John Magenau, M.D

Hematology-Oncology

University of Michigan, Department of Internal Medicine, Blood and Marrow Transplant Program

ANN ARBOR, MI

Last updated· May 2026 PI on 1 trialNPI: 1285833954

ℹ

Specialists are identified from ClinicalTrials.gov principal investigators, PubMed publications, and the NPI registry, then ranked through an automated scoring pipeline.

Report missing data

Rare diseases treated or studied

Based on trial PI assignments and publication topics.

Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement

Clinical trials (1)

NCT00556452

Verify independently

ClinicalTrials.gov PI search for John Magenau
NPPES NPI registry entry

Other specialists for Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement

Peers ranked by clinical-trial PI role, publications, and verification quality.

Stefan O Ciurea, MD
M.D. Anderson Cancer Center
CA
A. John Barrett, M.D.
National Heart, Lung, and Blood Institute (NHLBI)
Elizabeth Krakow, PhD
Fred Hutch/University of Washington Cancer Consortium
GA
Mitchell Horwitz, MD
Duke Health
NC
Charles A. Linker, MD, MD
University of California, San Francisco
CA
Rachel B. Salit, MD
Fred Hutch/University of Washington Cancer Consortium
WA
Zachariah DeFilipp, MD, M.D
Masachusetts General Hospital
GA
Brenda Sandmaier
Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium
WA

See all specialists for Myeloid/lymphoid neoplasm associated with FGFR1 rearrangement →

← Back to specialists directory